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INTRODUCTION
Malaria is caused by the parasite of the genus Plasmodium 
which is usually transmitted by the bite of an infected female 
anopheles mosquito. Plasmodium falciparum is the commonest 
species in Africa, and it accounts for up to 98% of the cases in 
Nigeria. Other species include P. malariae, P. ovale, and P. vivax. 
Malaria is endemic in most parts of Nigeria with stable trans-
mission all year round. High temperature, humidity, and rain-
fall are some of the factors that enhance mosquito breeding 
and malaria transmission [1]. Some of the major Anopheles 
species that transmit malaria in Nigeria are An. arabiensis, An. 
brochieri, An. coustani, An. flavicosta, An. funestus, and An. gam-
biae.
This disease remains one of the most terrible public health 
problems in Nigeria, causing about 60% of all outpatient at-
tendances and 30% of all hospital admissions. It is responsible 
for nearly 110 million clinical cases and an estimated 300,000 
deaths per year, including up to 11% of maternal mortality. 
Also, malaria’s economic impact is enormous with about N132 
billion lost to malaria annually in form of treatment costs, 
prevention, loss of man hours, and so on [2]. Pregnant wom-
en and children below the age of 5 years bear the greatest bur-
den of malaria in Nigeria, like many other endemic regions in 
Africa. Malaria in pregnancy was believed to contribute to 3-5% 
of maternal anemia, 8-14% of low birth weight (LBW), and 
3-8% of infant mortality [3]. In south-west Nigeria, past stud-
ies reported malaria parasite prevalence between 60% and 
72% among pregnant women [4,5].
Malaria programme coverage has increased substantially 
across Nigeria from 1991 to date. However, current coverage 
levels remain considerably under the targeted 60% levels es-
tablished in the previous plan and far below the levels (>60% 
coverage) at which major impact of the interventions on ma-
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Abstract: In Nigeria, malaria causes up to 11% of maternal mortality. Our main aim was to find out the most common 
mosquito control measures employed by the pregnant women in Lagos and their effects on malaria infection. The study 
was carried out over a period of 6 months during which trained interviewers administered questionnaires to 400 pregnant 
women. The prevalence of malaria was 8.4%. There was no significant association between the prevalence of malaria 
and age, level of education, or occupation of the participants. Pregnant women in the age range 26-30 had the mean par-
asite density (409.9±196.80). Insecticide spray (32.8%), mosquito coil (27.5%), and insecticide-treated nets (ITN) (15.5%) 
were the major mosquito control measures employed by the participants while the prevalence of infection among them 
were 2.3%, 6.2%, and 3.2%, respectively (P<0.05). Only 18.3% of the women had taken more than one dose of intermit-
tent preventive treatment (IPT), while another 11.8% had taken a single dose. The infection rate among them was 4.1% 
and 6.4%, respectively. Malaria prevalence was highest among those who had not received any dose of IPT (10%). This 
study showed that the use of ITN and IPT among the pregnant women were still unacceptably low. It also showed that 
the use of insecticide spray which was the most common malaria control measure adopted by the participants was effec-
tive despite the fact that it is not a National Malaria Control Policy. We recommend that a sustained integrated mosquito 
man-agement and public education should be strengthened in Nigeria.
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laria burden would be expected [2]. In a study carried out to 
evaluate the ownership and use of insecticide-treated nets (ITN) 
in Nigeria, Senegal, Uganda, and Zambia between 2000 and 
2004-2006, it was observed that there were large increases in 
the ownership in all countries. All countries but Nigeria made 
commensurate gains in the proportion of under-fives sleeping 
under a net/ITN, and in all countries the proportion of preg-
nant women sleeping under a net/ITN increased greatly, but 
none of the countries reached the ambitious Abuja targets for 
ITN use [6].
The efficacies of using indoor residual spray (IRS) and ITN 
against malaria vectors were compared (using data from 6 re-
cent comparisons in Africa, Asia, and Melanesia). By all the 
entomological and malariological criteria recorded, pyrethroid-
treated nets were at least as efficacious as house spraying with 
dichlorodiphenyltrichloroethane (DDT), malathion, or a pyre-
throid. However, when data from carefully monitored house 
spraying projects carried out between the 1950s and 1970s at 
3 different locations, including Garki (Nigeria) were compared 
with insecticide-treated net trials with apparently similar vec-
tor populations, the results with the ITN were much less im-
pressive. The possible explanations for this observation was 
said to include the longer duration of most of the earlier spray-
ing projects and the use of non-irritant insecticides. Non-irri-
tant insecticides are likely to kill mosquitoes more than the ir-
ritant pyrethroids, which tend to make insects leave the site of 
treatment (i.e. are excito-repellent) [7]. 
World Health Organization (WHO) currently advocates the 
use of Integrated Malaria Management (IMM) as the most ef-
fective tool to check the menace of malaria [8]. IMM consists 
of 3 tools: effective case management (ECM), integrated vector 
control (IVC), and personal protection (PP). These tools have 
to be applied simultaneously to be able to produce the desired 
impact. ECM is the use of effective antimalarial drugs to re-
move parasites from infected human hosts thereby preventing 
transmission to mosquitoes [9,10]. IVC is the use of adult mos-
quito killing measures, such as indoor insecticide sprays [11], 
and environmental management to remove the mosquito 
breeding sites, thus lowering the population densities of ma-
laria vectors. Personal protection includes measures that pre-
vent contact between man and mosquitoes, such as ITN [12], 
IRS, window, and door screens. Although the use of ITN alone 
has been shown to reduce malaria morbidity and mortality 
[13,14], there is no doubt that better results will be achieved 
when combined with the indoor insecticide spray. 
In addition to ITN, Roll Back Malaria (RBM) partnership 
recommends the use of intermittent preventive treatment (IPT) 
in areas of stable malaria transmission as a way of reducing 
the burden of this disease among pregnant women [15,16]. 
IPT consists of administration of curative dose of an effective 
anti-malarial drug at least twice during the second and third 
trimesters of pregnancy during routinely scheduled antenatal 
clinic visits regardless of whether the woman is infected or not 
[17,18]. The drug is administered under supervision during 
antenatal care visits. Sulfadoxine-pyrimethamine (SP) is the 
drug currently recommended for the IPT strategy [15,19]. Ni-
geria adopted this strategy in 2005. The current National Ma-
laria Treatment Guideline and Policy in Nigeria recommends 
SP as first line agent for IPT and quinine for treatment of clini-
cal malaria in all trimesters, Artemisinin-based combination 
therapy (ACT) is considered safe second line agents in the sec-
ond and third trimesters [16,20] and may be used in the first 
trimester where there are no suitable alternatives [20]. WHO 
expects 80% of all pregnant women living in areas of high trans-
mission to receive at least 2 doses of IPT during pregnancy by 
2010 [21]. 
Kenya was one of the first countries to implement IPT, but 
the national coverage with 2 doses of SP was only 4% at 5 years 
after implementation [22]. Compliance in Tanzania too was 
very low, and this has been linked to poor acceptance of SP 
because of perceived association with side effects [23]. In a re-
cent study to find out the knowledge and utilization of IPT 
among pregnant women attending antenatal clinics in prima-
ry health care centers in rural southwest, Nigeria, only 27.3% 
had received a dose of SP during the index pregnancy. The pro-
bable reason for the low uptake is the low level of awareness 
and poor knowledge of IPT by the pregnant women [24]. 
Indoor residual spray (IRS) is not yet adopted by the Na-
tional Malaria Control Policy in Nigeria [25], and the govern-
ment is practically doing nothing to encourage the use of in-
door insecticide spray when compared to the amount of hu-
man and material resources devoted to ITN and IPT. With this 
singular loophole IMM cannot be said to be a policy in Nige-
ria, especially not in pregnant women. Therefore, this study 
was carried out to evaluate the most common mosquito con-
trol measures employed by the pregnant women as well as 
their effects on malaria infection. The use of IPT with SP was 
also evaluated.   Efunshile et al.: Malaria control measures in pregnancy   367
MATERIALS AND METHODS
Study area
The study was conducted at Lagos Island Maternity Hospi-
tal, Lagos Nigeria. Lagos is situated in the southwestern part of 
Nigeria, an area of tropical rain forest with warm and humid 
climate where malaria transmission occurs all year round, like 
any other southern part of the country [25].
Ethical issues
Approval for the study was granted by the Lagos State Minis-
try of Health. Written informed consent was obtained from the 
participants. The questionnaires were administered by trained 
interviewers who interpreted the contents and the consent 
forms to those with poor understanding of English in local di-
alects. Those below the age of 18 years had their accompany-
ing husband or older relatives consent for them. 
Study population
The study was carried out over a period of 6 months between 
July and December 2009. All the pregnant women that con-
sented to participate in the study during this period (n=400) 
were interviewed for the study. Women who were sick of ma-
laria or any other form of illness were excluded from the study. 
Those who have taken antimalarial drugs within the last 4 weeks 
were also excluded. Questionnaires were administered to the 
participants so as to obtain information about their socio-de-
mographic characteristics, ITN usage, IPT usage, and pregnancy 
history. 
Evaluation of malaria prevention measures
The questionnaires elicited information about the usual mos-
quito control method adopted by participants and which has 
also been used in the previous night. They were also specifical-
ly questioned about the number of doses of IPT that has been 
taken under the supervision of health care workers during the 
antenatal visits had so far.
Sample collection
About 2 ml of venous blood was collected from the partici-
pants into EDTA bottles for malaria microscopy as well as for 
3 MM Whatman filter paper blood spots. 
Diagnosis of malaria
By antigen detection: SD BIOLINE Malaria Antigen P. falci-
parum (Korea), a malaria rapid diagnostic test kit (RDT) that 
detects histidin-rich protein-2 (HRP-2) specific for P. falciparum 
was used to initially screen the pregnant women at the point 
of sample collection. 
By microscopy: Thick and thin Giemsa-stained blood 
smears were examined for malaria parasites at Nigeria Institute 
of Medical Research (NIMR) by accredited laboratory scientists, 
using standard methods [26,27]. The parasite density was de-
termined in the thick film by counting the number of parasites 
against 200 leucocytes assuming the total leucocytes count to 
be 8,000 leucocytes/µl of blood. Parasite density was expressed 
as number of parasites per µl of blood. The thin film was used 
to verify the parasite specie. The hemoglobin (Hb) concentra-
tion of the women was also measured.
By species specific PCR for P. falciparum small subunit rRNA: 
Filter paper blots were transported from Nigeria to Germany 
where DNA was extracted using Tris-EDTA buffer-based extrac-
tion method [28], which yielded 100 μl of DNA in buffer. Nest-
ed PCR was carried out with primers described by Snounou et 
al. [29].Two genus-specific primers for Plasmodium spp. [-rPLU5-, 
(CCTGTTGTTGCCTTAAACTTC) and -rPLU6-, (TTAAAATTGTT-
GCAGTTAAAACG)] were used for the first cycle of amplifica-
tion. P. falciparum species was detected using species-specific 
primers [-rFAL1-, (TTAAACTGGTTTGGGAAAACCAAATATATT) 
and -rFAL2-, (ACACAATGAACTCAATCATGACTACCCGTC)] in 
the second cycle (nested) reaction. The PCR assays were per-
formed using the Peltier Thermal Cycler (PTC-0225) DNA En-
gine Tetrad (MJ Research inc., Walthan, Massachusetts, USA).
The thermal profile was 95˚C for 1 min (5 min at cycle 1), 
60˚C for 2 min and 72˚C for 2 min for 45 cycles. A volume of 
1 μl of the primary PCR product was used in the nested PCR 
reaction for 30 cycles. In both the first and nested PCR, reac-
tion volume was 25 μl. The final concentration of each reagent 
was 1× PCR reaction buffer (10× PCR buffer-MgCl2), 1.5 mM 
MgCl2, 125 μM dNTP, 250 nM primers and 0.02 U/μl Taq Poly-
merase (QIAGEN, Hilden, Germany). PCR products (1,100 bp 
and 205 bp, respectively) were visualized by gel electrophore-
sis and ethidium staining. 
Statistical methods
Analysis was performed using freely available GraphPad In-
stat 3.06 (San Digeo, California, USA). Non-parametric chi-
square test was performed to evaluate the relationship between 
presence and absence of malaria in relation to the observed 
characteristics. Two-sided P-values of <0.05 indicate statistical 368   Korean J Parasitol Vol. 49, No. 4: 365-371, December 2011
significance
RESULTS
The overview of the laboratory results is presented in Table 
1. The prevalence of infection with P. falciparum is dependent 
on the method used. Using microscopy, we detected a preva-
lence of 10%. Using the antigen test we got a prevalence of 
9.3% and with P. falciparum-specific nested PCR, the preva-
lence reached 8.5%. We have to keep in mind that the 2 latter 
methods detected only P. falciparum. Because of its high sensi-
tivity and specificity, PCR result was regarded as the true preva-
lence of infection.
The age distribution, level of education, and the occupation 
pattern of the pregnant women are presented in Table 2. Out 
of the 400 pregnant women involved in the study, their major-
ity were in the age range of 26 to 30 years (38.5%). The overall 
prevalence of the infection in the study population was 8.5%. 
The majority of the pregnant women were educated to the sec-
ondary and tertiary level (42.8% and 43.5%, respectively). Most 
of the participants were artisans (21.8%) and civil servants 
(21.8%), but malaria was most prevalent among the profes-
sionals (14.6%) and traders (14.0%). The secondgravidae had 
the lowest prevalence of malaria (5.3%) while the multigravi-
dae had the highest (9.8%) (P=0.426). Most of the women 
were in their 3rd trimester (67.8%) with infection rate of 8.9%. 
The prevalence of malaria was the highest among the primi-
gravidae (23.1%) (P=0.0068) (Table 3). Women within the 
age range of 16-20 years had the lowest mean hemoglobin 
concentration (8.0 g/dl) even though none of them was found 
with parasitemia. This was followed by the women older than 
35 years (9.9 g/dl). Women within the age range of 26-30 years 
had the highest mean parasite density of 409.9/µl of blood, 
this was followed by those in the age range of 21-25 years with 
130.9/µl (Table 4).
The most common malaria preventive measure was the use 
of insecticide spray (32.8%) , followed by the use of mosquito 
coil (27.5%). Only 15.5% depended on the use of ITN as the 
major mosquito control measure. The highest prevalence of 
infection was found among those who slept under an untreat-
ed net as the major control measure (28.0%). The infection rate 
Table 1. Results of malaria diagnosis
Age No. patients (%) No. RDT 
positive
No. microscopy 
positive 
No. PCR 
positive
16-20 7  (1.75) 0 0 0
21-25 96  (24.0) 8 9 7
26-30  154  (38.5) 21 22 19
31-35 99  (24.75)  6 7 6
>35 44  (11.0) 2 2 2
Total 400 (100.0) 37  40 34
RDT, rapid diagnostic test (antigen test).
Table 2. Characteristics of pregnant women involved in the study
Characteristics No. patients 
(%)
No. infected 
(%)
P-value
Age 16-20  7  (1.8)  0  0.387
21-25 96 (24.0) 7  (7.3) 
26-30 154 (38.5) 19 (12.3) 
31-35 99 (24.75)  6  (6.1)
>35 44 (11.0) 2  (4.6)
L  evel of  
education
Primary 36  (9.0) 4  (5.8) 0.155
Secondary 171 (42.8) 15  (8.8)
Tertiary 174 (43.5) 11  (6.3) 
None 19  (4.7) 4 (21.1)
Occupation Artisan 87 (21.8) 5  (5.8) 0.120
Civil servant 87 (21.8) 2  (2.3)
House wife 41 (10.3) 4  (9.8)
Professionals 48 (12.0) 7 (14.6) 
Students 58 (14.5) 7 (12.1)
Trading 43 (10.7) 6 (14.0)
Others 36  (9.0) 3  (8.3)
Table 3. Pregnancy status of the participants
Pregnancy status  No. patients (%) No. infected (%) P-value
Gravidity Primigravidae 183  (45.7)  17  (9.3)  0.4260
Secondgravidae 95  (23.8)  5  (5.3) 
Multigravidae 122  (30.5)  12  (9.8)
Total  400 (100.0)  34  (8.5)
Trimester 1st  26  (6.5)  6 (23.1) 0.0068*
2nd  103  (25.8)  4  (3.9) 
3rd  271  (67.8)  24  (8.9)
Total  400 (100.0)   34  (8.5)
*Significant.
Table 4. Mean hemoglobin (MH) level and mean parasite densi-
ty (MPD) of the participants
Age (years)
No. examined 
(%)
No. infected 
(%)
(MH) g/dl
(mean±SD)
MPD (Para-
site/µl)
(mean±SD)
16-20 7  (1.8) 0 8.0±0.4 0
21-25 96  (24.0) 7  (7.3) 10.1±1.1 130.9±52.3
26-30 154  (38.5) 19 (12.3) 10.0±1.3 409.9±196.8
31-35 99  (24.75) 6  (6.1) 11.1±1.4 63.0±59.3
>35 44  (11.0) 2  (4.6) 9.9±1.4 53.5±0.7
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was the lowest among those that used insecticide spray (2.3%), 
followed by those who employed the use of ITN (3.2%) to 
control mosquitoes (P=0.0001) (Table 5). Only 18.3% of the 
women have taken more than one dose of IPT during the in-
dex pregnancy, while 11.8% had taken only one dose. Yet, 70% 
were to take IPT. The prevalence of infection among the 3 groups 
was 4.1%, 6.4%, and 10.0%, respectively (P=0.086) (Table 6).
DISCUSSION
The prevalence of malaria in this study was 8.5%, this was 
largely different from previous studies in Lagos [5] and Osog-
bo [4], both in south-west Nigeria where the prevalence was 
between 60% and 72%, respectively. One reason for this large 
gap might be due to the diagnostic methods used. The overdi-
agnosis of malaria by microscopy must have occurred in previ-
ous studies. In this regard, overdiagnosis of malaria is not un-
common in endemic areas, for instance at 10 Tanzanian hos-
pitals, 39% of ‘positive’ malaria slides were false positives and 
at 17 Kenyan outpatient clinics, the positive predictive value of 
a ‘positive’ slide was only 22% (negative predictive value, 93%) 
when compared to expert microscopy [30,31]. To exclude over-
diagnosis of malaria, we used 3 different methods to detect 
parasitemia in the respective blood samples. Since nested PCR 
is the most specific and sensitive method, we relied on PCR re-
sults. Quite recently, the group around Agomo as well found a 
prevalence of 7.7% in a similar population in Lagos, Nigeria 
[32]. Furthermore, we only focused on P. falciparum which is 
the most import cause of malaria in Nigeria. 
This study showed that there was no significant association 
between gravidity and prevalence of malaria, though preva-
lence was highest in the multigravidae (9.9%). This disagreed 
with the study in Lagos where the highest prevalence of infec-
tion (9.1%) was found among the primigravidae [32]. 
Though the majority of women in this study were in their 
3rd trimester (67.8%), 6 of the 26 women in their 1st trimes-
ter were found to be positive with malaria parasites, this agrees 
with the general belief that malaria in pregnancy is common-
est in the 1st trimester [33]. 
The mean hemoglobin concentration of the women were 
generally low (8.0 to 11.1 g/dl). Women of age range 16-20 
years had the lowest level of hemoglobin (8.0 g/dl), paradoxi-
cally, none of them was positive for malaria parasite. This sug-
gested that other factors were contributory to anemia in these 
women. This agreed with the WHO position that more than 
half of the pregnant women in the world are anemic with he-
moglobin levels below 11 g/dl [34]. Similar results were seen 
among pregnant women in Abeokuta, Nigeria, which showed 
that 76.5% of the women investigated were anemic at 1 tri-
mester of pregnancy or another, late registration for antenatal 
care was said to be the major reason behind this [35]. System-
atic approach should be used to investigate the causes of ane-
mia in pregnancy in this population, so that effective control 
measures can be put in place. The parasite density (mean and 
SD) was the highest among the women in the age group 26-
30 years (409.9±196.80) who incidentally also had the high-
est prevalence of infection. It was the lowest in women who 
were over the age of 35 years (53.5±0.71).
The rate of ITN use in this study was low (15.5%). However, 
it showed an improvement in the rate of ITN usage among 
pregnant women in Nigeria, which was 4.4% in 2004 [6]. This 
may not be unconnected with increased funding of malaria 
control programs in the country within this period [25]. Insec-
ticide spray was the commonest means of mosquito control in 
this study with the users having the lowest malaria infection 
rate (2.3%). The infection rate was also low among those that 
depended on ITN as the major malaria control method (3.3%). 
The malaria infection rate was the highest among the women 
that used untreated bed nets as the major control method 
(28.0%). There was a significant association between malaria 
infection and the major control method adopted by the preg-
nant women (P=0.0001). Only 18.3% of the women had tak-
Table 5. Effect of insecticide-treated nets (ITN) and other control 
measures on malaria distribution 
Control measure No. patients (%) No. infected (%) P-value
ITN 62  (15.5) 2  (3.2)
Untreated bednet 50  (12.5) 14 (28.0)
Insecticide spray  131 (32.8) 3  (2.3)  0.0001*
Mosquito coil 110    (27.5) 7  (6.2)
Others  47  (11.8) 8 (17.0)
Total  400 (100) 34  (8.5)
*Significant.
Table 6. Effect of intermittent preventive therapy (IPT) usage on 
malaria infection
IPT Dose No. patients (%)  No. infected (%)  P-value 
>1dose 73 (18.3)   3 (4.1)
1 dose 47 (11.8)  3 (6.4) 
Not used  280  (70.0)  28 (10.0) 0.086
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en more than one dose of IPT, while another 11.8% had taken 
a single dose, and the infection rate among them was 4.1% 
and 6.4%, respectively. The malaria prevalence was the highest 
among those who have not received any dose of IPT (10%). 
This finding was consistent with reports from Ibadan and oth-
er African countries which found IPT with SP to be protective 
against malaria in pregnancy [17,36,37].
This study focused on mosquito control measures that were 
mostly practiced by the study population; it was possible that 
adjunct control measures existed that were occasionally em-
ployed and may also contributed to the observed parasitemia 
recorded in this investigation. Further studies may be designed 
to investigate this, and even to follow-up the women from the 
day of booking to the date of delivery so as to document the 
outcome of IPT and ITN on delivery.
In summary, our study showed that though use of insecti-
cide spray is not a policy in Nigeria, it is equally an effective 
malaria control strategy, and if properly implemented, it will 
impact positively on malaria control in Nigeria, especially if 
residual insecticides are deployed. The basic recommendation 
of a sustained integrated mosquito management which requi-
res alternative use of different classes of insecticides, in con-
junction with resistance monitoring, source reduction, biologi-
cal control, and public education [38] should be strengthened 
in Nigeria.
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